It’s Never Too Early.
Changes in the brains of people with Alzheimer’s Disease can begin up to 20 years before symptoms appear. TRAILRUNNER-ALZ 3 is a clinical research study for people who may have early Alzheimer’s disease or may be at risk for developing symptoms of Alzheimer’s disease.
To be eligible you must:
- Be between the ages of 55 and 80
- Have no to mild issues with your memory
- Have a blood test result that indicates the presence of early Alzheimer’s disease at study screening
- Be willing to travel to Ocala, FL for in-person visits
Those that qualify may:
- Receive access to potential new treatment options before the general public
- Receive study-related diagnostic tests, lab work and medical exams provided at no cost
- Receive compensation for time and travel associated with participation
No insurance is required to participate.